Peter Siesel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: May 18, 2021 IsoPlexis adds Switzerland as the latest country with access to their unique functional single-cell proteomics platform, adding to their existing partnerships across Asia and Europe. BRANFORD, Conn., May 18, 2021 /PRNewswire/ -- IsoPlexis, the leader in single-cell proteomics, today announced an exclusive agreement with Bucher Biotec AG, a Swiss distributor company representing some of the most advanced US, European, and Asian manufacturers of highly innovative life science research instrumentation, associated reagents, and consumables. This agreement follows Iso...

Share this article Share this article BRANFORD, Conn., May 13, 2021 /PRNewswire/ -- IsoPlexis, the leader in single-cell proteomics, today announced that Jason Ou has joined the company as General Manager for the Asia-Pacific (APAC) region. In this role, Mr. Ou will continue to advance IsoPlexis' growth and expand the company's customer base in the APAC region. "We are pleased to have Jason join our leadership team at IsoPlexis," said Peter Siesel, Chief Commercial Officer of IsoPlexis. "Jason has an extensive track record of leadership, solution-oriented thinking, and customer satisfact...